Insilico Medicine uses AI to discover novel SIK2 inhibitors
Reviewers’ Notes Insilico Medicine ("Insilico"), a clinical-stage end-to-end generative artificial intelligence (AI) drug discovery company, has achieved a significant breakthrough […]
Want to see rapid results in the gym? Scientists discover ‘magic number’ of times you should go per week Australian […] A world-first human trial at James Cook University using live hookworms to combat diseases such as type 2 diabetes has […] High cholesterol: Nutritionist reveals top prevention tips Cholesterol is not all bad. A small amount of the waxy substances helps […] Reviewers’ Notes NYU Langone Health once again stands out in U.S. News & World Report's annual "Best Hospital" rankings for […] Equivalent after the third dose Unexpectedly good protection among the vulnerable Source: Read Full Article Being exposed to lead contamination as a child may turn you into a CRIMINAL as an adult, study suggests – […] Relatives of Henrietta Lacks, an African-American woman whose unwittingly harvested cancer cells spawned revolutionary advances in medicine, has reached a […] Dr Christine Kay A gene therapy that aims to increase levels of two key proteins that enable the growth of […] In a recent study published in the Science Advances Journal, a group of researchers developed potent monoclonal antibodies from a […]Health News
Want to see results in the gym? You DON'T need to work-out every day
World-first human trial: Experimental hookworm infection led to improvements in type 2 diabetes patients
Expert recommends ‘great’ summer drink to bust your high cholesterol levels
NYU Langone Health included on the 2023-24 Honor Roll of top 20 hospitals
Three doses of COVID-19 vaccine leads to catch-up antibody responses among the particularly vulnerable, finds study
Children exposed to lead are more likely to become criminals: Review
US family reaches deal over cells harvested in 1950s
Study: AMD Gene Therapy Demonstrates Vision Stabilization
New study spotlights effective strategy against COVID-19 variants: the E7 monoclonal antibody